Ultraviolet recall phenomenon associated with methotrexate and cytarabine. (Record no. 16114539)

MARC details
000 -LEADER
fixed length control field 01389 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515015606.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200607s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0926-9959
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1468-3083.2006.01432.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kaya, T I
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060724
245 00 - TITLE STATEMENT
Title Ultraviolet recall phenomenon associated with methotrexate and cytarabine.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of the European Academy of Dermatology and Venereology : JEADV
Date of publication, distribution, etc. Mar 2006
300 ## - PHYSICAL DESCRIPTION
Extent 353-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytarabine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diagnosis, Differential
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Hypersensitivity
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Non-Hodgkin
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Methotrexate
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ultraviolet Rays
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tiftik, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tursen, U
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ikizoglu, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yalcin, A
773 0# - HOST ITEM ENTRY
Title Journal of the European Academy of Dermatology and Venereology : JEADV
Related parts vol. 20
-- no. 3
-- p. 353-4
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1468-3083.2006.01432.x">https://doi.org/10.1111/j.1468-3083.2006.01432.x</a>
Public note Available from publisher's website

No items available.